Asia-Pacific Genetic Testing Market Outlook to 2024

Publisher Name :
Date: 01-Dec-2017
No. of pages: 85

Asia-Pacific Genetic Testing Market Outlook to 2024

Summary

GlobalData's new report, Asia-Pacific Genetic Testing Market Outlook to 2024, provides key market data on the Asia-Pacific Genetic Testing market. The report provides value, in millions of US dollars within market segments - Acquired Gene or Chromosome Alterations, Inborn Gene or Chromosome Alterations and Other Genetic Tests

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size and company share data for Genetic Testing market segments - Acquired Gene or Chromosome Alterations, Inborn Gene or Chromosome Alterations and Other Genetic Tests

- Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2010 to 2017 and forecast to 2024.

- 2017 company shares and distribution shares data for each of the market segments.

- Global corporate-level profiles of key companies operating within the Asia-Pacific Genetic Testing market.

- Key players covered include F. Hoffmann-La Roche Ltd, Abbott Laboratories and Luminex Corp.

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.

- Develop market-entry and market expansion strategies.

- Design competition strategies by identifying who-stands-where in the market.

- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

- What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Asia-Pacific Genetic Testing Market Outlook to 2024

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Introduction 6
2.1 What Is This Report About? 6
2.2 Genetic Testing Market Segmentation 6
2.3 Definitions of Markets Covered in the Report 7
3 Genetic Testing Market, Asia-Pacific 8
3.1 Genetic Testing Market, Asia-Pacific, Revenue ($m), 2010-2024 8
3.2 Genetic Testing Market, Asia-Pacific, Category Comparison by Revenue ($m), 2010-2024 10
3.3 Genetic Testing Market, Asia-Pacific, Revenue ($m), 2010-2017 12
3.4 Genetic Testing Market, Asia-Pacific, Revenue ($m), 2017-2024 14
3.5 Genetic Testing Market, Asia-Pacific, Company Share by Revenue ($m), 2017 16
4 Genetic Testing Market, Australia 18
4.1 Genetic Testing Market, Australia, Revenue ($m), 2010-2017 18
4.2 Genetic Testing Market, Australia, Revenue ($m), 2017-2024 20
4.3 Genetic Testing Market, Australia, Distribution Share by Revenue ($m), 2017 22
4.4 Genetic Testing Market, Australia, Company Share by Revenue ($m), 2017 23
5 Genetic Testing Market, China 25
5.1 Genetic Testing Market, China, Revenue ($m), 2010-2017 25
5.2 Genetic Testing Market, China, Revenue ($m), 2017-2024 27
5.3 Genetic Testing Market, China, Distribution Share by Revenue ($m), 2017 29
5.4 Genetic Testing Market, China, Company Share by Revenue ($m), 2017 30
6 Genetic Testing Market, India 32
6.1 Genetic Testing Market, India, Revenue ($m), 2010-2017 32
6.2 Genetic Testing Market, India, Revenue ($m), 2017-2024 34
6.3 Genetic Testing Market, India, Distribution Share by Revenue ($m), 2017 36
6.4 Genetic Testing Market, India, Company Share by Revenue ($m), 2017 37
7 Genetic Testing Market, Japan 39
7.1 Genetic Testing Market, Japan, Revenue ($m), 2010-2017 39
7.2 Genetic Testing Market, Japan, Revenue ($m), 2017-2024 41
7.3 Genetic Testing Market, Japan, Distribution Share by Revenue ($m), 2017 43
7.4 Genetic Testing Market, Japan, Company Share by Revenue ($m), 2017 44
8 Genetic Testing Market, South Korea 46
8.1 Genetic Testing Market, South Korea, Revenue ($m), 2010-2017 46
8.2 Genetic Testing Market, South Korea, Revenue ($m), 2017-2024 48
8.3 Genetic Testing Market, South Korea, Distribution Share by Revenue ($m), 2017 50
8.4 Genetic Testing Market, South Korea, Company Share by Revenue ($m), 2017 51
9 Overview of Key Companies in Asia-Pacific Genetic Testing Market 53
9.1 F. Hoffmann-La Roche Ltd 53
9.1.1 Company Overview 53
9.2 PerkinElmer Inc 53
9.2.1 Company Overview 53
9.3 Abbott Laboratories 53
9.3.1 Company Overview 53
9.4 Qiagen NV 54
9.4.1 Company Overview 54
9.5 Hologic Inc 54
9.5.1 Company Overview 54
10 Genetic Testing Market Pipeline Products 55
11 Recent Developments 58
11.1 Corporate Communications 58
11.1.1 Oct 29, 2017: George Church, a world-renowned scientist, joins the scientific advisory board of CloudHealth Medical Group to advise on the strategic development of their "pan-omics" direct to consumer platform 58
11.1.2 Jul 20, 2017: Meridian Announces Wholly Foreign Owned Enterprise Office in Beijing, China 58
11.1.3 Apr 11, 2017: VolitionRx Appoints David Vanston as Chief Financial Officer 59
11.1.4 Nov 28, 2016: Micell Technologies Announces First Patient Enrolled In Landmark Registration Trial Of MiStent In Japan 59
11.2 Financial Announcements 60
11.2.1 Aug 09, 2017: VolitionRx Announces Second Quarter 2017 Financial Results and Business Update 60
11.2.2 Jul 27, 2017: Genetic Technologies: Quarterly Activities Report and Appendix 4C of the ASX Listing Rules for the quarter ended 30 June 2017 61
11.2.3 May 11, 2017: VolitionRx Announces First Quarter 2017 Financial Results and Business Update 63
11.2.4 Mar 10, 2017: VolitionRx Announces Full Fiscal Year 2016 Financial Results and Business Update 64
11.2.5 Jan 31, 2017: Vela Diagnostics, a turnkey manufacturer for IVD NGS and PCR workflow solutions announces its 2016 results and highlights 65
11.2.6 Nov 10, 2016: VolitionRx Announces Third Quarter 2016 Financial Results and Business Update 66
11.3 Legal And Regulatory 66
11.3.1 Jul 19, 2017: TBG Diagnostics Received ASHI accreditation for Xiamen facility 66
11.4 Other Significant Developments 67
11.4.1 Oct 30, 2017: Genetic Technologies Quarterly Activities Report and Appendix 4C of the ASX Listing Rules for the quarter ended 30 September 2017 67
11.4.2 Oct 17, 2017: WuXi NextCODE Integrates Oxford Nanopore into the Global Platform for Genomic Data 69
11.4.3 Sep 25, 2017: Baylor Genetics Partners With Rainbow Genomics Offering Adult Wellness Screening and High-Risk Cancer Exome Sequencing Tests in Asian Pacific 70
11.4.4 Aug 25, 2017: Genetic Technologies Announces Comprehensive Review of Strategic Alternatives 70
11.4.5 Aug 22, 2017: Volition Signs Agreement with the Institute of Laboratory Medicine of the Technical University of Munich, Germany, to assist in securing large trials in a range of cancers 71
11.4.6 Aug 16, 2017: FDA Accepts Supplemental Biologics License Application and Grants Priority Review for ADCETRIS (Brentuximab Vedotin) in Cutaneous T-Cell Lymphoma 71
11.4.7 Apr 10, 2017: CloudHealth Genomics Makes China's First Sequencing Data Available Using Illumina's NovaSeq 6000 73
11.4.8 Mar 07, 2017: Vela Genomics Launches NGS Clinical Interpretation and Reporting 73
11.4.9 Jan 23, 2017: Oxford BioDynamics enters into pilot project with EpiFit to analyse the effect of fitness regimes using EpiSwitch 73
11.4.10 Jan 04, 2017: GrandOmics Biosciences Expands Investment in PacBio's Sequel Systems for Precision Medicine Initiative 74
11.5 Product News 75
11.5.1 Oct 23, 2017: TBG Biotechnology First to Receive China FDA Approval for High Resolution HLA Genotyping for Hematopietic Cell Transplantation 75
11.5.2 Jun 02, 2017: Macrogen Launches Special Promotion on Exome Sequencing to Celebrate Their 20th Anniversary 75
11.5.3 Apr 26, 2017: Seegene Unlocks the Door to the Next Level of the Real-time PCR Business 76
11.5.4 Mar 09, 2017: New test to monitor the success of bone marrow transplants 77
11.5.5 Feb 23, 2017: CloudHealth Genomics Presents their Unique Market Strategy and ImmuneSeq Panel for both Cancer and Non-Cancer Immunotherapies 77
12 Appendix 79
12.1 Research Methodology 80
12.1.1 Coverage 80
12.1.2 Secondary Research 80
12.1.3 Primary Research 81
12.1.4 Market Modeling and Forecasting 82
12.1.5 Company Share Analysis 83
12.1.6 Distribution Share Analysis 84
12.1.7 Benchmarking 84
12.2 GlobalData Consulting 84
12.3 Contact Us 85
12.4 Disclaimer 85

1.1 List of Tables
Table 1: Genetic Testing Market, Cross Country Comparison, Asia-Pacific, Revenue ($m), USD Constant, 2010-2024 9
Table 2: Genetic Testing Market, Asia-Pacific, Category Comparison by Revenue ($m), USD Constant, 2010-2024 11
Table 3: Genetic Testing Market, Asia-Pacific, Revenue ($m), Historic, USD Constant, 2010-2017 13
Table 4: Genetic Testing Market, Asia-Pacific, Revenue ($m), Forecast, USD Constant, 2017-2024 15
Table 5: Genetic Testing Market, Asia-Pacific, Company Share by Revenue ($m), USD Constant, 2017 17
Table 6: Genetic Testing Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 19
Table 7: Genetic Testing Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 21
Table 8: Genetic Testing Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2017 22
Table 9: Genetic Testing Market, Australia, Company Share by Revenue ($m), USD Constant, 2017 24
Table 10: Genetic Testing Market, China, Revenue ($m), USD Constant, Historic, 2010-2017 26
Table 11: Genetic Testing Market, China, Revenue ($m), USD Constant, Forecast, 2017-2024 28
Table 12: Genetic Testing Market, China, Distribution Share by Revenue ($m), USD Constant, 2017 29
Table 13: Genetic Testing Market, China, Company Share by Revenue ($m), USD Constant, 2017 31
Table 14: Genetic Testing Market, India, Revenue ($m), USD Constant, Historic, 2010-2017 33
Table 15: Genetic Testing Market, India, Revenue ($m), USD Constant, Forecast, 2017-2024 35
Table 16: Genetic Testing Market, India, Distribution Share by Revenue ($m), USD Constant, 2017 36
Table 17: Genetic Testing Market, India, Company Share by Revenue ($m), USD Constant, 2017 38
Table 18: Genetic Testing Market, Japan, Revenue ($m), USD Constant, Historic, 2010-2017 40
Table 19: Genetic Testing Market, Japan, Revenue ($m), USD Constant, Forecast, 2017-2024 42
Table 20: Genetic Testing Market, Japan, Distribution Share by Revenue ($m), USD Constant, 2017 43
Table 21: Genetic Testing Market, Japan, Company Share by Revenue ($m), USD Constant, 2017 45
Table 22: Genetic Testing Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 47
Table 23: Genetic Testing Market, South Korea, Revenue ($m), USD Constant, Forecast, 2017-2024 49
Table 24: Genetic Testing Market, South Korea, Distribution Share by Revenue ($m), USD Constant, 2017 50
Table 25: Genetic Testing Market, South Korea, Company Share by Revenue ($m), USD Constant, 2017 52
Table 26: Genetic Testing Market Pipeline Products 55
Table 27: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country 82

1.2 List of Figures
Figure 1: Genetic Testing Market, Cross Country Comparison, Asia-Pacific, Revenue ($m), USD Constant, 2010-2024 8
Figure 2: Genetic Testing Market, Asia-Pacific, Category Comparison by Revenue ($m), USD Constant, 2010-2024 10
Figure 3: Genetic Testing Market, Asia-Pacific, Revenue ($m), Historic, USD Constant, 2010-2017 12
Figure 4: Genetic Testing Market, Asia-Pacific, Revenue ($m), Forecast, USD Constant, 2017-2024 14
Figure 5: Genetic Testing Market, Asia-Pacific, Company Share (%) 2017 16
Figure 6: Genetic Testing Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 18
Figure 7: Genetic Testing Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 20
Figure 8: Genetic Testing Market, Australia, Company Share (%) 2017 23
Figure 9: Genetic Testing Market, China, Revenue ($m), USD Constant, Historic, 2010-2017 25
Figure 10: Genetic Testing Market, China, Revenue ($m), USD Constant, Forecast, 2017-2024 27
Figure 11: Genetic Testing Market, China, Company Share (%) 2017 30
Figure 12: Genetic Testing Market, India, Revenue ($m), USD Constant, Historic, 2010-2017 32
Figure 13: Genetic Testing Market, India, Revenue ($m), USD Constant, Forecast, 2017-2024 34
Figure 14: Genetic Testing Market, India, Company Share (%) 2017 37
Figure 15: Genetic Testing Market, Japan, Revenue ($m), USD Constant, Historic, 2010-2017 39
Figure 16: Genetic Testing Market, Japan, Revenue ($m), USD Constant, Forecast, 2017-2024 41
Figure 17: Genetic Testing Market, Japan, Company Share (%) 2017 44
Figure 18: Genetic Testing Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 46
Figure 19: Genetic Testing Market, South Korea, Revenue ($m), USD Constant, Forecast, 2017-2024 48
Figure 20: Genetic Testing Market, South Korea, Company Share (%) 2017 51
  • United States Rapid Medical Diagnostic Kits Market Report 2017
    Published: 11-Dec-2017        Price: US 3800 Onwards        Pages: 116
    In this report, the United States Rapid Medical Diagnostic Kits market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market sha......
  • Global Women's Health Diagnostics Market Size, Status and Forecast 2022
    Published: 06-Dec-2017        Price: US 3300 Onwards        Pages: 101
    This report studies the global Women's Health Diagnostics market, analyzes and researches the Women's Health Diagnostics development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like - Siemens Healthineers - F. Hoffmann-La Roche - Abbott Laboratories - Hologic - BD Medical - Acon Laboratories - Philips - GE Healthcare - bioMerieux - M......
  • Global Rapid Medical Diagnostic Kits Sales Market Report 2017
    Published: 06-Dec-2017        Price: US 4000 Onwards        Pages: 126
    In this report, the global Rapid Medical Diagnostic Kits market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Rapid Medical Diagnostic Kits for these regions, from 2012 to 2022 (forecast), covering - United States - China ......
  • Global Pneumonia Testing Market Research Report 2017
    Published: 04-Dec-2017        Price: US 2900 Onwards        Pages: 119
    In this report, the global Pneumonia Testing market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Pneumonia Testing in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China -......
  • Global Drug of Abuse Testing Market Professional Survey Report 2017
    Published: 01-Dec-2017        Price: US 3500 Onwards        Pages: 103
    This report studies Drug of Abuse Testing in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - Roche Holding Limited - Quest Diagnostics - Laboratory Corporation of......
  • North America Genetic Testing Market Outlook to 2024
    Published: 01-Dec-2017        Price: US 5995 Onwards        Pages: 381
    North America Genetic Testing Market Outlook to 2024 Summary GlobalData's new report, North America Genetic Testing Market Outlook to 2024, provides key market data on the North America Genetic Testing market. The report provides value, in millions of US dollars within market segments - Acquired Gene or Chromosome Alterations, Inborn Gene or Chromosome Alterations and Other Genetic Tests The report also provides company shares and distribution shares data f......
  • North America Histology And Cytology Market Outlook to 2024
    Published: 01-Dec-2017        Price: US 5995 Onwards        Pages: 70
    North America Histology And Cytology Market Outlook to 2024 Summary GlobalData's new report, North America Histology And Cytology Market Outlook to 2024, provides key market data on the North America Histology And Cytology market. The report provides value, in millions of US dollars within market segments - Flow Cytometers, Immunmodulators, Monoclonal Antibodies, Polyclonal Antibodies and Tissue Typing Reagents The report also provides company shares and di......
  • North America Immuno Chemistry Market Outlook to 2024
    Published: 01-Dec-2017        Price: US 5995 Onwards        Pages: 459
    North America Immuno Chemistry Market Outlook to 2024 Summary GlobalData's new report, North America Immuno Chemistry Market Outlook to 2024, provides key market data on the North America Immuno Chemistry market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments - Complement Deficiency Tests, Diabetes Assays, Disease Specific Immunochemistry, Endocrinology Tests, IgE Allergy Blood Tests, Immunochemist......
  • EU5 Genetic Testing Market Outlook to 2024
    Published: 01-Dec-2017        Price: US 5995 Onwards        Pages: 176
    EU5 Genetic Testing Market Outlook to 2024 Summary GlobalData's new report, EU5 Genetic Testing Market Outlook to 2024, provides key market data on the EU5 Genetic Testing market. The report provides value, in millions of US dollars within market segments - Acquired Gene or Chromosome Alterations, Inborn Gene or Chromosome Alterations and Other Genetic Tests The report also provides company shares and distribution shares data for each of these market segmen......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs